% | $
Quotes you view appear here for quick access.

OraSure Technologies, Inc. Message Board

  • retiredtechie retiredtechie Jan 18, 2011 11:15 AM Flag

    RT: Its Too Early To Buy OSUR-Q4 Will Take It Down

    If you get a chance, take a look at the Q3/2010 report for OSUR. The outlook as expressed by the company for the Q4/2010 period calls for significantly reduced revenue, higher expenses and an $.08 to .09 cent loss for the period. That report should take the wind out of this stock from current share pricing. I expect a 20% haircut once that report is made public and that should bring the share price back down into the $5.00/share area. Long term meaning 12 to 24 months, I see OSUR as having very good capital appreciation potential, however, I believe its much too early to climb aboard at this time. I would recommend holding off buying this stock until after the Q1/2011 report is released. That report will give everyone much better clarity going forward.

    Cheers and good investing,

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From one 70-something to another, your analysis may be right on the money. But do u really think this share price is gradually clawing its way back based on 2010 events? Yes, it may, indeed, have a pullback when earnings are announced. And if folks have a profit so far, who can fault them for taking profits. I'm one of those who likes what 's in the pipeline, in addition to the OTC possibility, and will hold what I've got, sit back and wait. We'll see.

      • 3 Replies to gben1938
      • are people buying this stock for the HCV product or over-the-counter HIV test?

      • gben1938:

        I really can't fault you for looking over the immediate horizon with OSUR, because as you say, OSUR's product pipeline holds tremendous future potential. From my standpont as a "watcher" of this stock and not holding any shares, I simply see some months of rough going given the fact the company has already mentioned they will report strong head winds when they report their Q4/2010 operations. From my view point, its appears to be somewhat over priced at this time. I happen to be a long term player of stocks myself, however, I've learned over many years not to jump too quickly. Timing is everything in this game. The air surrounding OSUR needs to be cleared to some degree and I don't see that happening until about the middle of this new year. Since I'm tossing some cold water on your stock for the moment, I should at least tell you where you should be able to find some quick upside action leading into the longer term. Take a good look at Oculus Innovative Sciences (OCLS). That's a stock that I see as having the same type of future potential as OSUR. The only difference being that its now ready for a significant move to the upside and its currently priced right. If you do investigate OCLS, tell me what you think of it. As for myself, I'm currently carrying a serious position in OCLS and I continue to be a strong buyer with the idea of holding it for at least 12 to 24 months. You will find my postings over at that Yahoo-Finance site. Beyond the above, I should tell you that I'm strictly into micro cap med-tech, bio-tech and related healthcare stocks. That's my comfort zone in the stock market. Its an area that has been very good to me over many, many years.

        Cheers and good investing,

      • looks more like MMs are simply walking it up on 100-share trades, absent real buyers.

7.05+0.32(+4.75%)1:59 PMEDT